Maravai LifeSciences Holdings, Inc. MRVI Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s operating cash flow?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported operating cash flow of $8.67M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s operating cash flow changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s operating cash flow increased by 192.3% year-over-year, from -$9.39M to $8.67M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s operating cash flow?
- Over 3 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s operating cash flow has grown at a -46.1% compound annual growth rate (CAGR), from $368.57M to -$57.57M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.